Implementation of the REPRISE care bundle model for the prevention of pressure ulcers in an intensive care unit: An experimental study Authors: Zeynep Cor, Ganime Esra Soysal Published: 2024 ABSTRACT AbstractThe aim of this study was to evaluate the effectiveness of the REPRISE care bundle (CB) model for pressure ulcer (PU) prevention in intensive care patients and to determine the impact of the training provided to nurses on their knowledge base and attitudes. This study has an experimental design. The study was conducted in the anaesthesia and resuscitation intensive care unit on a total of 72 patients. The prevalence of PU was compared between the control group and the REPRISE‐CB group. For the nurses, 50 nurses working in the ICU were included in the study. The nurses' knowledge and attitudes towards PU were compared before and after the training. The data were analysed using a statistical program. The incidence of IW was significantly lower in the intervention group (13.9%) compared to the control group (38.9%) (p < 0.05). The study showed that oedema, low albumin levels, low mean blood pressure and low Braden Scale scores were significant risk factors for the development of PU. In addition, the training provided to nurses was found to significantly improve their knowledge and attitudes (p < 0.05). It was concluded that REPRISE‐CB was effective in the prevention of PU and that nurses' knowledge increased with training.Keywords: care bundles, evidence‐based practice, intensive care units, nursing, pressure ulcer INTRODUCTION A pressure ulcer (PU) is defined as a localized injury to the skin and/or subcutaneous tissue, typically occurring over bony prominences, caused by prolonged pressure and/or shear forces, in isolation or in conjunction with lacerations. 1 PUs represent a significant global health concern, with patients often experiencing prolonged hospitalization, loss of labour force, and reduced quality of life. These complications are not only physically and emotionally distressing for patients but also result in increased healthcare costs and a greater demand for nursing resources. 2 It is possible to identify PU before it occurs with appropriate interventions. For this purpose, the European Pressure Ulcer Advisory Panel (EPUAP), the National Pressure Injury Advisory Panel (NPIAP) and the Pan Pacific Pressure Injury Alliance (PPPIA) have determined some measures such as risk assessment, skin assessment, nutritional assessment, positioning, use of support surfaces and prevention of PU caused by medical devices. 1 Although PU prevention can be achieved through a multidisciplinary approach, one of the most crucial steps in this process is nursing care. 3 Implementation of evidence‐based practices (EBPs) alone and without a plan may be more difficult for nurses, and consistency in PU prevention practices for nurses may be possible by performing EBPs together and in a planned manner. 4 , 5 , 6 Guidelines recommend the use of EBPs and CB in the prevention of PU. In the study, it was reported by Mao et al. that the incidence of PU development was lower in the group using CB. 7 In addition, Rivera et al. reported that fewer PUs occurred in patients followed up with CB compared to the control group, whereas Al Otaibi et al. reported an 84% decrease in PU prevalence after the use of CB. 8 , 9 The assessment and evaluation of the efficacy of the implementation of bundles represents a pivotal aspect of the process of translating evidence‐based interventions into clinical practice. 10 It is seen that very few studies have been conducted with CB application to prevent PU and the studies conducted were mostly conducted to evaluate the views of nurses. In the studies that have been conducted, CB applications have been shown to be successful in PU prevention and it is reported that more experimental studies are needed. 7 , 8 , 9 This may necessitate the implementation of more effective and individualized care strategies. The aim of the study was (1) to evaluate the effectiveness of REPRISE‐CB for PU prevention in intensive care unit and (2) to evaluate the effect of PU education given to nurses on their knowledge levels and attitudes. MATERIALS AND METHODS Study design This study is experimental research conducted in a state hospital anaesthesia and reanimation intensive care unit between 15 May 2023 and 15 September 2023. In the initial phase of the study, the data for the patients in the control group were collected first. Following the administration of REPRISE‐CB training to the nursing staff, the data of the patients in the intervention group were collected. The primary outcome was the determination of PU rates in both groups, with a view to evaluating the effectiveness of REPRISE‐CB. The secondary outcome was a comparison of patients in terms of parameters such as age, gender, oedema, skin turgor, albumin, haemoglobin, glucose, blood pressure, and Braden scale scores. In the second phase, the effectiveness of CB training given to nurses for PU prevention was evaluated. Sample selection In the first part, the population of the study consists of patients hospitalized in anaesthesia and reanimation intensive care unit. The sample consists of patients who were hospitalized between April and August 2023, met the inclusion criteria and agreed to participate in the study. When calculating the sample size, a total of 72 patients, 36 in the control and intervention groups, were reached at 95% power and 0.05 significance level according to the power analysis (power, 1‐β) performed in the G*Power 3.1.9.7. Patients recruited before the nurse training and REPRISE‐CB application constituted the control group, and patients recruited afterwards constituted the intervention group. The inclusion criteria for the patients included in the study were determined as follows: being 18 years of age or older, not developing PU in any part of the body, staying in the clinic for at least 72 h or more and having a Braden score below 15 points. Patients with PU in any part of the body, with a Braden score of more than 15, who were exited, discharged or transferred from intensive care to another service without completing the number of days determined during the data collection phase were not included in the sample group. The second part of the study was conducted with nurses working in the anaesthesia and reanimation ICU. There was a total of 50 nurses in the unit where the study was conducted and constituted the population of the study. Data collection ‘Patient Identification Form’, ‘Braden Pressure Ulcer Risk Assessment Scale’, and ‘Care Bundle Data Collection Form for Preventing Pressure Ulcer Development’ were used in the control and intervention groups. Patients were followed up for 30 days in each group. After the control group data were completed, CB training was given to the nurses working in ICU. The content of the training was given to the nurses as a booklet and care bundle posters were hung on the wall. ‘Nurses Descriptive Characteristics Form’ and ‘Assessment of Nurses Knowledge and Attitudes Towards Prevention of Pressure Ulcers Form’ were used before and after the training. (Figure 1). Flow chart of the study. Patient Identification Form: Socio‐demographic information including age, gender, smoking, alcohol consumption, height and weight, body mass index (BMI), days of hospitalization and ICU stay, Glasgow Coma Scale (GCS), intubation status, chronic diseases, albumin and haemoglobin values, presence/absence of PU, and if PU occurred, its location and stage were recorded. 1 , 11 , 12 , 13 Braden Pressure Ulcer Risk Assessment Scale: The scale developed by Braden and Bergstorm in 1987 considering PU risk factors of patients is the most widely used risk assessment tool. 14 REPRISE‐CB Data Collection Form for Preventing Pressure Ulcers Development: This form was prepared by the researcher in accordance with EPUAP/NPIAP/PPPIA 2019 guidelines and consists of seven parameters compatible with the educational content. 1 Pressure Ulcer Prevention REPRİSE Care Bundle Training Booklet and Poster: It was created by the researcher to be given to nurses working in the clinic: PU definition, stages, risk factors, body parts where PU develops most frequently, nursing interventions required to prevent PU, and PU prevention CB (risk assessment, skin assessment, nutrition assessment, incontinence management, positioning, pressure ulcers caused by medical devices). Ten expert opinions were obtained for the prepared training material and the necessary arrangements were made and finalized. Training content and REPRISE‐CB implementation steps: Risk Assessment: The assessment was performed at the time of admission of the patient to the clinic and then repeated every 8‐h shift and recorded. Risk Assessment: The assessment was performed at the time of admission of the patient to the clinic and then repeated every 8‐h shift and recorded. Evaluation of the skin: It was repeated at the first hospitalization of the patient in the clinic and every 8 h to include the whole skin. The skin was checked for redness, moisture, temperature and oedema and skin assessment was performed again after the contact of medical devices with the skin and the patient's bed sheet was ensured to be clean, dry and stretched. Evaluation of the skin: It was repeated at the first hospitalization of the patient in the clinic and every 8 h to include the whole skin. The skin was checked for redness, moisture, temperature and oedema and skin assessment was performed again after the contact of medical devices with the skin and the patient's bed sheet was ensured to be clean, dry and stretched. Incontinence Management: Perianal area was kept clean against urinary and faecal incontinence. Incontinence Management: Perianal area was kept clean against urinary and faecal incontinence. Evaluation of Nutrition: A standard nutritional screening was performed in all patients admitted to the clinic and an appropriate nutritional programme and fluid intake were planned. Evaluation of Nutrition: A standard nutritional screening was performed in all patients admitted to the clinic and an appropriate nutritional programme and fluid intake were planned. Repositioning: Unless there was no contraindication, the positions of the patients were planned and applied to be repositioned every 2 h (straight, right–left lateral). Repositioning: Unless there was no contraindication, the positions of the patients were planned and applied to be repositioned every 2 h (straight, right–left lateral). Support Surfaces: Foam mattresses, mattresses with microclimate properties, and pressure‐dispersing mattresses were used in individuals at high risk of PU development and in individuals for whom positioning was not indicated. Support Surfaces: Foam mattresses, mattresses with microclimate properties, and pressure‐dispersing mattresses were used in individuals at high risk of PU development and in individuals for whom positioning was not indicated. Prevention of Pressure Ulcers Caused by Medical Devices: Patients were evaluated and controlled against PU formation caused by the medical devices used in the patients. In patients receiving non‐invasive oxygen support, hydrocolloid products were used on the nose under CBAP masks (Figure 2). Prevention of Pressure Ulcers Caused by Medical Devices: Patients were evaluated and controlled against PU formation caused by the medical devices used in the patients. In patients receiving non‐invasive oxygen support, hydrocolloid products were used on the nose under CBAP masks (Figure 2). REPRİSE care bundle model. The REPRISE care bundle represents a more innovative and comprehensive approach to pressure ulcer prevention than existing care bundles. It offers significant improvements in these areas compared to existing care packages, including dynamic risk assessment, more systematic skin and nutritional assessments, a proactive approach to incontinence management and specific strategies to prevent injuries related to medical devices. Following the collection of data from the control group, the nurses underwent training on the seven‐step application created with REPRISE‐CB. The nursing staff applied and recorded all of the care package steps for each patient. Nurses Descriptive Characteristics Form and Assessment of Nurses Knowledge and Attitudes Towards Prevention of Pressure Ulcers Form: These forms were created by the researcher by examining the literature. The descriptive form consists of age, gender, marital status, years of working in the profession, and the unit worked in. The other form consists of a total of 30 questions including the evaluation of nurses' knowledge and attitudes towards PU prevention. 1 , 15 Statistical analysis The data from the study were analysed using a computer program. Descriptive statistical methods (numbers, percentages) were used to evaluate the data. Skewness and kurtosis values between ±2 were accepted to determine whether the data used showed a normal distribution or not. 16 Parametric tests were used in statistical evaluations for scales with normal distribution and nonparametric tests were used for scales without normal distribution. For the comparison of quantitative data for scales with normal distribution, independent sample t test was used to compare the difference between two groups and Mann–Whitney U was used to compare the difference between two groups without normal distribution. Chi‐square test was used for categorical variables. Statistical significance value was accepted as p < 0.05. Ethical considerations Approval was obtained from the University Clinical Research Ethics Committee on 20.03.2023 with decision number 2023/37. All procedures were performed in compliance with relevant laws and institutional guidelines. This study is registered at clinicaltrials.gov as NCT06509399. RESULTS The results of the study were analysed in two stages. Firstly, the results regarding the effect of REPRISE‐CB on the prevention of PU and, secondly, the results regarding the nurses' knowledge and attitudes towards the prevention of PU were analysed. Effect of REPRISE‐CB in preventing PU When the descriptive characteristics of the patients in the control and intervention groups were analysed, it was seen that gender, age, intubation status, GCS scores and chronic diseases (except hypertension) were similar in most of the patients and there was no statistical difference between the groups (p > 0.05). When the BMI of the patients in the intervention group was analysed, it was seen that the index score was higher and hypertension diseases were statistically higher than the control group (p < 0.05) (Table 1). TABLE 1Descriptive characteristics of patients (n:72).Control (n:36)Application (n:36)Statistical analysis/pGenderFemale17 (47.2)15 (41.7)0.225/0.635k Male19 (52.8)21 (58.3)Age. mean ± sd71.86 ± 12.7772 ± 14.280.367/0.965t Height (cm). mean ± sd165.69 ± 8.97168.41 ± 8.40−1.328/0.188t Weight (kg). mean ± sd82.47 ± 17.4677.53 ± 13.93 465.5/0.04 u BMI30.37 ± 6.4327.39 ± 4.39 468.5/0.04 u Intubation35 (97.2)36 (100)1.014/0.314k GCS Week 14.92 ± 2.694.86 ± 2.670.088/0.930t GKS Week 25.03 ± 2.864.83 ± 2.670.298/0.767t GKS Week 35.53 ± 3.765 ± 3.220.179/0.525t GKS Week 45.60 ± 4.164.97 ± 3.290.706/0.483t Chronic diseases n (%) n (%)DM21 (58.3)17 (47.2)0.892/0.345k Hypertension27 (75.0)14 (38.9) 9.574/0.002 k PVH2 (5.6)0 (0.0)2.057/0.151k CRF3 (8.3)2 (5.6)0.215/0.643k CVE14 (38.9)15 (41.7)0.058/0.810k COPD15 (41.7)18 (50.0)0.503/0.478k CAD6 (16.7)9 (25.0)0.758/0.384k HF11 (30.6)8 (22.2)0.643/0.422k Note: k: Chi‐square test. t: Independent t test. u: Mann–Whitney U test. p ≤ 0.05. Bold indicates statistically significant values (p < 0.05).Abbreviations: CAD, Coronary Artery Disease; COPD, Chronic Obstructive Pulmonary Disease; CRF, Chronic Renal Failure; CVE, Cerebrovascular Event; DM, Diabetes Mellitus; GCS, Glasgow Coma Scale; HF, Heart Failure; PVH, Pulmonary Venous Hypertension. Descriptive characteristics of patients (n:72). Note: k: Chi‐square test. t: Independent t test. u: Mann–Whitney U test. p ≤ 0.05. Bold indicates statistically significant values (p < 0.05). Abbreviations: CAD, Coronary Artery Disease; COPD, Chronic Obstructive Pulmonary Disease; CRF, Chronic Renal Failure; CVE, Cerebrovascular Event; DM, Diabetes Mellitus; GCS, Glasgow Coma Scale; HF, Heart Failure; PVH, Pulmonary Venous Hypertension. The primary outcome measure was the occurrence of pressure injury in the two groups. As Table 2 was analysed, it was determined that 38.9% of the patients in the control group had PU formation, while 13.9% of the patients in the REPRISE‐CB group had PU formation and a statistically significant difference was found (p < 0.05). In the control group, the rate of PU formation was 33.3% in the sacrum, 25.0% in the heels and 11.1% in the trochanters, whereas in the intervention group, it was 8.3% in the sacrum, 5.6% in the heels and 5.6% in the thochanters. In terms of the site of PU formation, the rate of PU formation in the sacrum and heels in the control group was statistically significantly higher than in the REPRISE‐CB group (p < 0.05). The mean day of the first PU formation was 9.50 ± 2.68 days in the control group and 21.20 ± 3.11 days in the REPRISE‐CB group, and it was observed that the pressure wound opened earlier in the control group than in the REPRISE‐CB group (p < 0.05). TABLE 2Pressure ulcer occurrence status of patients (n: 72).Control (n:36)Application (n:36)Statistical analysis (p) n (%) n (%)Formation of pressure injuryYes14 (38.9)5 (13.9) 5.791/0.016 k No22 (61.1)31 (86.1)Site of pressure injurySacrum12 (33.3)3 (8.3) 6.821/0.009 k Heel9 (25.0)2 (5.6) 5.258/0.022 k Torah edges4 (11.1)2 (5.6)0.727/0.394k Mean ± sdMean ± sdThe first day of the pressure injury9.50 ± 2.6821.20 ± 3.11 8.050/0.000 t Length of hospital stay24.39 ± 6.8429.67 ± 1.14 4.562/0.000 t Length of stay in intensive care unit24.39 ± 6.8429.67 ± 1.14 4.562/0.000 t Note: k: Chi‐square test. t: Independent t test, p ≤ 0.05. Bold indicates statistically significant values (p < 0.05). Pressure ulcer occurrence status of patients (n: 72). Note: k: Chi‐square test. t: Independent t test, p ≤ 0.05. Bold indicates statistically significant values (p < 0.05). By looking at the secondary outcomes of the study in Table 3, analyses are given according to age, gender, oedema, skin turgor, albumin, haemoglobin, glucose, blood pressure, and Braden scale scores between the two groups according to the occurrence of PU in the control group and the REPRISE‐CB group. No statistically significant result was found between the occurrence of PU according to gender, age, BMI, hospitalization day and postprandial glucose values (p > 0.05). When all patients were considered, it was determined that PU occurred in 58.6% of patients with oedema and 4.7% of patients without oedema and there was a statistically significant difference (p < 0.05). While PU occurred in 70.8% of patients with decreased skin turgor and 4.2% of patients with normal skin turgor, the mean albumin value of patients with PU was 2.19 ± 0.32, the mean albumin value of patients without PU was 2.94 ± 0.42 and the difference was statistically significant (p < 0.05). The mean haemoglobin value was 9.62 ± 1.50 in patients with PU and 10.87 ± 1.87 in patients without PU, and it was statistically significant (p < 0.05). The mean arterial blood pressure was 72.59 ± 10.92 in patients with PU and 82.21 ± 13.11 in patients without PU, the mean Braden scale score of patients with PU was 9.28 ± 0.88 and the mean Braden scale score of patients without PU was 10.82 ± 1.56, which was statistically significant (p < 0.05). TABLE 3Pressure injury in patients according to independent variables (N: 72).Control group (n:36)Application group (n:36)Sum (N:72)Mean ± sd/(n, %)Statistical analysis (p)Mean ± sd/(n, %)Statistical analysis (p)Mean ± sd/(n, %)Statistical analysis (p)Pressure injuryYesNoYesNoYesNoGender (n, %)Male10 (52.6)9 (47.4)3.197/0.074k 2 (9.5)19 (90.5)0.803/0.630k 12 (30.0)28 (70.0)0.604/0.437k Female4 (23.5)13 (76.5)3 (20.0)12 (80.0)7 (21.9)25 (78.1)Age; mean ± sd72 ± 10.6771.77 ± 14.190.051/0.959t 72.20 ± 16.3171.96 ± 14.230.033/0.974t 72.05 ± 11.8971.88 ± 1.930.046/0.964t BMI29.06 ± 6.9631.21 ± 6.09−0.98/0.334t 27.62 ± 4.7127.35 ± 4.420.128/0.899t 28.89 ± 7.0634.80 ± 8.62−0.585/0.560t Hospitalization day26.07 ± 5.7423.32 ± 7.391.183/0.245t 30 ± 0.029.61 ± 1.230.695/0.49t 27.11 ± 5.1927 ± 5.720.070/0.944t Oedema (n, %)Yes13 (56.5)10 (43.5) 8.333/0.004 k 4 (66.7)2 (33.3) 16.769/0.000 k 17 (58.6)12 (41.4) 25.970/0.000 k No1 (7.7)12 (92.3)1 (3.3)29 (96.7)2 (4.7)41 (95.3)Skin turgor (n, %)Normal2 (10.5)17 (89.5) 13.619/0.000 k 029 (100) 24.055/0.000 k 2 (4.2)46 (95.8) 36.608/0.000 k Decreased12 (70.6)5 (29.4)5 (71.4)2 (28.6)17 (70.8)7 (29.2)Albumin2.28 ± 0.393.07 ± 0.60 −4.273/0.000 t 2.16 ± 0.262.94 ± 0.40 −4.085/0.000 t 2.19 ± 0.322.94 ± 0.42 −6.458/0.000 t Haemoglobin7.83 ± 1.689.25 ± 2.60−1.803/0.0809.14 ± 0.6410.98 ± 1.89 −2.132/0.040 t 9.62 ± 1.5010.87 ± 1.87 −2.605/0.011 t Postprandial glucose174.61 ± 49.46164.88 ± 39.650.652/0.519t 176.75 ± 40.76153.02 ± 35.821.351/0.186t 174.06 ± 44.47157.48 ± 36.941.589/0.117t MABP* 70.72 ± 11.8373.17 ± 9.11−0.701/0.48877.58 ± 7.3188.69 ± 11.54 −2.073/0.046 t 72.59 ± 10.9282.21 ± 13.11 −2.858/0.006 t Braden9.14 ± 0.9210.31 ± 1.54−2.556/0.015t 9.70 ± 0.6711.17 ± 1.50 −2.135/0.040 t 9.28 ± 0.8810.82 ± 1.56 −4.018/0.000 t Note: k: Chi‐square test. t: Independent t test. Bold indicates statistically significant values (p < 0.05). Note: Bold indicates statistically significant values (p ≤ 0.05).*MAP, Mean Arterial Blood Pressure; p ≤ 0.05. Note: Bold indicates statistically significant values (p ≤ 0.05). Pressure injury in patients according to independent variables (N: 72). Note: k: Chi‐square test. t: Independent t test. Bold indicates statistically significant values (p < 0.05). Note: Bold indicates statistically significant values (p ≤ 0.05). MAP, Mean Arterial Blood Pressure; p ≤ 0.05. Note: Bold indicates statistically significant values (p ≤ 0.05). Nurses' knowledge and attitudes towards preventing PU At this stage of the study, the effectiveness of the CB training prepared for the prevention of PU given to nurses was analysed. It is seen that 68% of the nurses working in the ICU who participated in the study were female, 68% were married, 76% were undergraduate graduates and the average working time in the profession was 114.20 ± 72.162 (months) (Table 4). TABLE 4Descriptive characteristics of nurses (n:50). n %GenderFemale3468.0Male1632.0Marital statusMarried3468.0Single1632.0Educational backgroundHealth vocational high school24.0Pre‐Bachelor's degree36.0Bachelor's degree3876.0Graduate714.0Mean ± ssMin–MaxAge32.54 ± 6.521–47Time spent working (months)114.20 ± 72.1624–334 Descriptive characteristics of nurses (n:50). When Table 5 is analysed, it is seen that the pre‐test and post‐test scores of the nurses working in intensive care before and after the training for the evaluation of their knowledge and attitudes towards the prevention of PU were statistically significant (p < 0.05). It is seen that the scale score knowledge and attitudes of the nurses increased statistically significantly after the training (p < 0.05). TABLE 5Evaluation of nurses' knowledge and attitudes towards pressure injury prevention. Comparison of pre‐test and post‐test score averages (n: 50).Mean ± sd, Min–Max n RankSum of ranks Z Statistical analysis (p)Assessment of nurses knowledge and attitudes towards prevention of pressure ulcer form pre‐test 1.96 ± 0.21 1.12–2.54 Negative ranks3428.16170.504.198w 0.0001* Assessment of nurses knowledge and attitudes towards prevention of pressure ulcer form Post‐test 2.31 ± 0.35 1.52–3.76 Positive ranks1313.12957.50Ties3Total50Abbreviation: W, Wilcoxon Marked Rank Test.* p ≤ 0.05. Evaluation of nurses' knowledge and attitudes towards pressure injury prevention. Comparison of pre‐test and post‐test score averages (n: 50). 1.96 ± 0.21 1.12–2.54 Assessment of nurses knowledge and attitudes towards prevention of pressure ulcer form Post‐test 2.31 ± 0.35 1.52–3.76 Abbreviation: W, Wilcoxon Marked Rank Test. p ≤ 0.05. DISCUSSION The extant literature does not provide conclusive evidence that gender is an effective factor in the formation of PU. It has been documented that gender‐related differences in the prevention of pressure ulcers are generally considered to be minimal. 17 Gender is reported as an independent risk factor for PU formation. 17 , 18 Our study is similar to the gender distribution in other studies, and it is seen that there is no risk factor for PU. Increased comorbidities and frailty with ageing are the risk factors for PU. 19 , 20 Studies have reported a 63.6% increase in PU in patients over the age of 65, and being over the age of 60 is a risk factor. 21 , 22 In our study, the mean age of the patients with PU in the control group was 72 ± 10.67, while this ratio was 72.20 ± 16.31 in the intervention group. In addition, the statistical analysis for the age variable between the control and intervention groups was not significant and the groups were homogeneous (p > 0.05). In patients with high BMI, PU is caused by less vascular structure due to increased tension power as a result of increased BMI. 23 In addition, the risk of PU development especially in the tissue under the bones increases as a result of low BMI. It has been reported that there is a direct relationship between BMI and PU, and even a 1 kg increase increases the risk of PU. 24 , 25 The absence of an association between BMI and PU occurrence in our study may be attributed to the relatively low degree of obesity or cachexia observed in the patient sample. Furthermore, the control group exhibited higher mean weight and BMI values, with a statistically significant difference between the two groups (p < 0.05). The higher prevalence of PU in the control group, when assessed in the context of BMI, provides further evidence for the potential influence of other factors. One of the most important risk factors for the development of PUs in ICU patients is the length of stay in the ICU. 26 However, studies have shown that there was no significant difference between the number of days of hospitalization and PU in their study in which they used CB to prevent PU. 7 , 27 In our study, although the duration of hospitalization was longer in the REPRISE‐CB group, the fact that PU was less may be due to the CB effect. One of the reasons why there was no significant difference between the duration of hospitalization and PU in all patients is thought to be that the patients in the sample group were followed up for 30 days. A significant correlation between GCS and PU has been reported. 28 The GCS scores of the control group and the intervention group were similar for 4 weeks (p > 0.05). In our study, no significant relationship was found between GCS and PU. The reason for the difference from the literature may be the patient group sampled, the characteristics of the ICU where the study was conducted and the fact that the majority of the patients in the sample had low GCS scores. Tayyib et al. reported that there was no significant correlation in the occurrence of PU in terms of chronic diseases of the patients in the control and application groups in their CB study for PU prevention. 29 Dave et al. also reported that most of the patients in the control group had chronic diseases. 27 In this study, 58.3% of the patients in the control group had DM, 75% had HT and 5.6% had PVH, while 47.2% of the patients in the intervention group had DM, 38.9% had HT and 0% had PVH. Especially HT and DM are similar to other studies. In this study, no significant relationship was found between PU formation and chronic diseases. This may be due to the fact that both groups had similar chronic diseases. Albumin forms an important part of plasma proteins and accounts for 60% of the total plasma protein content. 30 Serum albumin has essential functions such as maintaining plasma oncotic pressure and plasma volume, transporting hormones, vitamins, oligominerals and drugs and playing a powerful antioxidant‐anti‐inflammatory role. Low albumin level causes interstitial oedema, accelerates the development of PU and delays wound healing. 31 Considering the studies, there is a significant relationship between PU and low albumin level. 22 , 32 , 33 In this study, the results were consistent with the literature; mean albumin was lower in patients with PU and higher in patients without PU. When haemoglobin level decreases, oxygen‐carrying capacity of the blood and tissue resistance decreases significantly and ischemia occurs. 34 Low haemoglobin had a significant relationship with PU formation, and in a study carried out, PU occurred in 17.5% of patients with low haemoglobin and 2.1% of patients without low haemoglobin. 35 , 36 In the REPRISE‐CB group, the mean haemoglobin of those who developed PU was lower. In light of these results, it can be said that low haemoglobin is an important step in the prevention of PU. Studies show that the use of CB can prevent PUs more effectively than clinical guidelines. Altaş et al. showed that PUs occurred in 100% of the patients in the non‐CB group and 61.2% of the patients in the CB group and the difference was not statistically significant. 37 There are studies reporting that the rate of PU formation before CB decreased after CB application. 38 Mao et al. reported that PU formation in the control group was significantly higher than in the application group. 7 Tayyib et al. similarly showed that the PU rate was 32.86% in the non‐CB group and 7.14% in the CB group, which was statistically significant. 29 Zhang et al. applied PU prevention CB consisting of risk assessment, skin care, position, support surfaces and nutrition parameters in ICUs and the PU rate decreased from 13.86% to 10.41% and decreased by 29.5% in 6 months. 39 It has been reported that the use of a support surface is effective to prevent PU in patients undergoing open heart surgery. 40 In our study, patients in the control group developed PU more frequently than patients in the REPRISE‐CB group. Studies have shown that PU occurs most frequently in the sacrum, heel, gluteal region and coccyx. 29 , 37 , 41 In our study, it was observed that the highest PU occurred in the sacrum and heels of the patients in the control group, respectively. In this respect, our results are similar to the results of other studies. There are studies in the literature showing that the knowledge levels of nurses related to the trainings given for PU prevention increased at the same time their attitude scores. 38 , 42 , 43 Different from the previous studies, in this study, it was observed that PU rates in patients decreased with the CB model they applied in patient care in addition to increasing the knowledge level of nurses (p < 0.05). The limitations of this study are that as it was conducted in a single ICU, the control group data and patient pressure ulcer development rates and nurse knowledge levels were measured prior to any application. After the nurses were given PU prevention REPRISE‐CB training, bundle steps were applied and then the data of the intervention group were collected. Therefore, a complete randomization could not be established in patient selection. The results of this study clearly demonstrate the effectiveness of the developed CB in the prevention of PU in ICUs. In particular, it was found that patients in the REPRISE‐CB group developed PU at a lower rate compared to the control group. These findings suggest that CB is an important tool in reducing the risk of PU. In addition, oedema, low albumin value, low mean blood pressure and low Braden scale score were found to be important risk factors for PU development. These findings emphasize that careful monitoring and management of risk factors is critical in PU prevention strategies. It is recommended that all nurses working in ICUs receive regular training on PU prevention. It is recommended that continuing education be incorporated into the care of pressure ulcers in intensive care units, with the aim of enhancing the quality of care provided. 44 , 45 , 46 The findings of the study demonstrate that the training programme had a significant impact on the knowledge and attitudes of the nurses. It is therefore recommended that EBPs for PU prevention should be integrated into the nurses' daily care practices. Furthermore, the implementation of systematic care approaches such as REPRISE‐CB in other hospitals and an evaluation of its effectiveness may increase its potential to become a widespread solution for PU prevention. The findings of this study are highly generalizable and applicable to a range of clinical settings and similar patient groups. However, further studies with larger sample sizes are required to confirm the efficacy of REPRISE‐CB. FUNDING INFORMATION None declared and no external funding. CONFLICT OF INTEREST STATEMENT No conflict of interest has been declared by the authors. ETHICS STATEMENT Approval was obtained from the University Clinical Research Ethics Committee on 20.03.2023 with decision number 2023/37. All procedures were performed in compliance with relevant laws and institutional guidelines. This study is registered at clinicaltrials.gov as NCT06509399. ACKNOWLEDGEMENTS This study was carried out as a master's thesis in Bolu Abant Izzet Baysal University, Institute of Postgraduate Education, Department of Nursing. The authors thank all nurses in the intensive care unit for their participation in the study and for their sensitivity in the implementation of the REPRISE Care Bundle. Cor Z, Soysal GE. Implementation of the REPRISE care bundle model for the prevention of pressure ulcers in an intensive care unit: An experimental study. Int Wound J. 2024;21(12):e70138. doi: 10.1111/iwj.70138 DATA AVAILABILITY STATEMENT Data available on request due to privacy/ethicalrestrictions. REFERENCES Associated Data Data Availability Statement Data available on request due to privacy/ethicalrestrictions.